Clincosm LogoSign in Get a demo

Adenocarcinoma

Showing 1 - 25 of 170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Recruiting
  • Adenocarcinoma
  • +2 more
  • collection of biological samples
  • Bordeaux, France
  • +7 more
Nov 20, 2023

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Ethmoid Sinus Tumor, Adenocarcinoma, Circulating Tumor Cell Trial (Liquid biopsy)

Not yet recruiting
  • Ethmoid Sinus Tumor
  • +2 more
  • Liquid biopsy
  • (no location specified)
Oct 18, 2023

Prostatic Tumor, Adenocarcinoma, Tumor Recurrence Trial in Rennes, Pointe-à-Pitre (Standard care)

Recruiting
  • Prostatic Neoplasm
  • +3 more
  • Standard care
  • Rennes, Ille-et-Vilaine, France
  • +1 more
Sep 14, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma Trial in Houston (TROP2-CAR-NK, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Pancreatic Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 27, 2023

HER2-positive Locally Advanced/Metastatic Gastric and/or

Not yet recruiting
  • Adenocarcinoma
    • Arkhangelsk, Russian Federation
    • +40 more
    May 29, 2023

    Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

    Not yet recruiting
    • Head and Neck Cancer
    • +8 more
    • Tumor and HLA Profiling
    • (no location specified)
    Mar 31, 2023

    Esophageal Cancer, Gastric Cancer, Adenocarcinoma Trial in United States (Niraparib)

    Recruiting
    • Esophageal Cancer
    • +2 more
    • Tampa, Florida
    • +3 more
    Jan 18, 2023

    Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound

    Recruiting
    • Hilar Cholangiocarcinoma
    • +4 more
    • Endoscopic Ultrasound registration
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus University Medical Center
    Jan 11, 2023

    Sputum DNA Testing for Lung Cancer in China

    Recruiting
    • Lung Cancer
    • +15 more
    • Diagnostic Test: Sputum DNA methylation analysis
    • chest CT or pathological examination
    • Guangzhou, Guangdong, China
      Nanfang Hospital of Southern Medccal University
    Dec 29, 2022

    Cancer Pain, Adenocarcinoma Trial in Ottawa (Methadone, Morphine)

    Withdrawn
    • Cancer Pain
    • Adenocarcinoma
    • (no location specified)
    Dec 1, 2022

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • New York, New York
    • +1 more
    Nov 7, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma Trial in France, Italy, Spain (Standard treatment: Control arm,

    Not yet recruiting
    • Cervical Carcinoma
    • +2 more
    • Standard treatment: Control arm
    • Experimental arm
    • Bordeaux, France
    • +18 more
    Oct 12, 2022

    Tumor, Adenocarcinoma Trial in Houston (Pembrolizumab, lenvatinib)

    Recruiting
    • Tumor
    • Adenocarcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 13, 2022

    Prostate Cancer, Adenocarcinoma, Prostatic Tumors Trial (bpMRI, Image-Fusion targeted and systematic Biopsy)

    Not yet recruiting
    • Prostate Cancer
    • +4 more
    • bpMRI
    • Image-Fusion targeted and systematic Biopsy
    • (no location specified)
    Oct 7, 2022

    Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

    Recruiting
    • Lung Neoplasms
    • +23 more
    • La Jolla, California
    • +35 more
    Oct 6, 2022

    Resectable or Locally Advanced Borderline Pancreatic

    Active, not recruiting
    • Pancreas Cancer
    • Adenocarcinoma
      • Paris, France
        Groupe Hospitalier Paris Saint-Joseph
      Aug 19, 2022

      Subjects Previously Enrolled on NCI Surgery Branch Studies

      Enrolling by invitation
      • Melanoma
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 18, 2022

        Prostatic Tumors, Adenocarcinoma Trial in United States (JNJ-69086420)

        Recruiting
        • Prostatic Neoplasms
        • Adenocarcinoma
        • Duarte, California
        • +7 more
        Aug 2, 2022

        Lung Tumors, NSCLC, Lung Diseases Trial in Worldwide (CK-101)

        Completed
        • Lung Neoplasms
        • +3 more
        • Sarasota, Florida
        • +19 more
        Jul 25, 2022

        Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

        Recruiting
        • Lung Neoplasm
        • +26 more
        • Boston, Massachusetts
        • +6 more
        Jun 23, 2022

        Metastatic Cancer, Carcinoma, Adenocarcinoma Trial in Cleveland (18F-Clofarabine)

        Recruiting
        • Metastatic Cancer
        • +2 more
        • Cleveland, Ohio
          Cleveland Clinic, Case Comprehensive Cancer Center
        May 11, 2022